RUPARIB 300MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: EMCURE PHARMACEUTICALS LTD (CANCER CARE)

MRP: ₹29945.46

Ruparib 300mg Tablet by Emcure (rucaparib 300mg, 60 tablets) is a PARP inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for maintenance treatment of ovarian cancer after response to platinum chemotherapy, and BRCA-mutated prostate cancer. Schedule H: dispense only against a valid prescription. Counselling point: sun sensitivity is common; advise sun protection.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.